Keurig Green Mountain, Inc. Securities Litigation (2011)

According to the Complaint, Keurig Green Mountain, Inc. ("GMCR" or the "Company") and its subsidiaries operate in the specialty coffee and coffee maker businesses. The Company has achieved significant growth in recent years, driven by sales from its popular Keurig single-cup brewing system, which uses "K-Cup" portion packs to brew single servings of coffee and other beverages.

See Case Details »

LRR Energy, L.P. Securities Litigation

According to the Complaint, it is alleged the Proposed Acquisition is designed to unlawfully divest LRR Energy unitholders of the Company's valuable assets for grossly inadequate consideration and without fully disclosing all material information concerning the transaction to unitholders.

See Case Details »

Pershing Square Capital Management, L.P. : Allergan, Inc. Derivative Securities Litigation

This action stems from the illicit insider trading and front-running scheme that caused billions of dollars in damages. During the Class Period, Pershing Square Capital Management, L.P., PS Management GP, LLC, William Ackman, PS Fund 1, LLC ("PS Fund 1"), Pershing Square, L.P., Pershing Square II, L.P., Pershing Square GP, LLC , Pershing Square International and Pershing Square Holdings, Ltd. (collectively, "Pershing"), through a funding vehicle named PS Fund 1 purchased over 14 million Allergan shares at prices as low as $117.91 per share for a total cost of approximately $2 billion. Pershing's purchases were based upon inside information concerning Valeant Pharmaceuticals International, Inc.'s ("Valeant") plans to launch a hostile takeover and tender offer for Allergan, and allowed Pershing to reap enormous profits at the expense of Plaintiff and other members of the Class.

See Case Details »

Akari Therapeutics, Plc Securities Litigation

According to the law firm press release, the complaint filed in this class action lawsuit alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose: (1) that the Company's CEO, and possibly other executives, were involved in publishing false information about the Company, including false information about the Phase 2 PNH trial of Coversin; (2) that the Company lacked adequate checks and protections to prevent such behavior; and (3) that, as a result of the foregoing, Defendants' statements about Akari's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

See Case Details »

Alliance MMA, Inc. Securities Litigation

According to the law firm press release, the lawsuit alleges defendants in connection with Alliance MMA's initial public offering made false and/or misleading statements and/or failed to disclose that: (1) the condensed consolidated financial statements for the three months ended June 30, 2016 could not be relied upon because of an error in recognizing as compensation transfers of common stock by an affiliate of Alliance MMA to individuals who were at the time of transfer, or subsequently became, officers, directors or consultants of Alliance MMA; (2) the condensed consolidated financial statements for the six months ended June 30, 2016 could not be relied upon because of an error in recognizing as compensation transfers of common stock by an affiliate of Alliance MMA to individuals who were at the time of transfer, or subsequently became, officers, directors or consultants of Alliance MMA; and (3) as a result, defendants' statements about Alliance MMA's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

See Case Details »